Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism. (nature.com)

Authors: Canaria DA … Yi T Journal: Nature Published: 2026-10-14 DOI: https://doi.org/10.1038/s41586-026-11176-1